Home
Conditions
Immunoproliferative Disorders

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,947 public trials 2,015 recruiting studies

Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Recruiting

Combining Loncastuximab Tesirine and Epcoritamab in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)

NCT07197307

Conditions: Aggressive Diffuse Large B-cell Lymphoma, Follicular Lymphoma (FL) Grade 3B, Hemic and Lymphatic Diseases, +12 more
Locations: Universitätsklinikum Münster, Medizinische Klinik A Münster, Germany

Universitaetsklinikum Aachen Aachen, Germany

Universitaetsklinikum Augsburg Augsburg, Germany

Vivantes Netzwerk fuer Gesundheit Berlin, Germany

View all 34 locations

View Trial Details

Recruiting

Long-term Follow up Local Registry Study of Kymriah in South Korea

NCT06785818

Conditions: B-Cell Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Burkitt Lymphoma, DNA Virus Infections, +17 more
Locations: Novartis Investigative Site Bundang Gu, Gyeonggi-do, South Korea

Novartis Investigative Site Seongnam-si, Gyeonggi-do, South Korea

Novartis Investigative Site Gyeonggi-do, Korea, South Korea

Novartis Investigative Site Incheon, Korea, South Korea

View all 18 locations

View Trial Details

Recruiting

Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax

NCT05724121

Conditions: Arrhythmias, Cardiac, Atrial Fibrillation, Cardiac Arrhythmias, +32 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Recruiting

Phase 2 Study Of Mosunetuzumab In Patients With Chronic Lymphocytic Leukemia With Positive MRD

NCT07566364

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: UT MD Anderson Houston, Texas, United States

View Trial Details

Recruiting

A Clinical Study of SHR-5421 in Patients With Multiple Myeloma

NCT07652281

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Peking University People's Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

Pilot Trial of Fecal Microbiota Transplantation for Lymphoma Patients Receiving Axicabtagene Ciloleucel Therapy.

NCT06218602

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations: MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Pre-transplant Purging and Post-transplant MRD-guided Maintenance Therapy With Elranatamab in Patients With High-risk Multiple Myeloma

NCT06207799

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

Personalized NK Cell Therapy in CBT

NCT02727803

Conditions: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, +55 more
Locations: M D Anderson Cancer Center Houston, Texas, United States

View Trial Details

Recruiting

A Study of Lacutoclax (LP-108) in Patients With Relapsed/Refractory CLL/SLL

NCT07609823

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +15 more
Locations: The First Affiliated Hospital of Nanjing Medical University Nanjing, Jiangsu, China

View Trial Details

Recruiting

Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis

NCT01441089

Conditions: Adnexal Diseases, Breast Cancer, Breast Diseases, +37 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Immunoproliferative Disorders

Immunoproliferative Disorders trial results

Related conditions